A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents
Phase of Trial: Phase IV
Latest Information Update: 11 May 2017
At a glance
- Drugs Phentermine/topiramate (Primary)
- Indications Obesity; Sleep apnoea syndrome; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors VIVUS
- 30 Nov 2016 Status changed from active, no longer recruiting to completed.
- 10 Aug 2016 Planned End Date changed from 1 Jun 2016 to 1 Nov 2016.
- 10 Aug 2016 Planned primary completion date changed from 1 May 2016 to 1 Oct 2016.